BTS
PTLA

BB&T Securities’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BB&T Securities’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$568K Buy
20,854
+2,389
+13% +$67.1K 0.01% 1050
2019
Q2 		$500K Buy
18,465
+2,879
+18% +$90.3K ﹤0.01% 1097
2019
Q1 		$540K Buy
+15,586
New +$450K 0.01% 1037
2018
Q4 		– Sell
-7,603
Closed -$202K – 1646
2018
Q3 		$202K Buy
7,603
+2,275
+43% +$74.3K ﹤0.01% 1481
2018
Q2 		$201K Buy
+5,328
New +$204K ﹤0.01% 1452

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

BB&T Securities's PTLA Position: Q3 2019 in Review

BB&T Securities increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 13% in Q3 2019, buying an estimated $67.1K and bringing the position to 20,854 shares worth $568K. The position accounts for 0.01% of the portfolio, ranked #1050.

BB&T Securities first reported a position in PTLA in Q2 2018 and has held it in 5 quarters since. 212 funds tracked by Wall St. Rank hold PTLA as of Q3 2019.

  • BB&T Securities held 20,854 shares of Portola Pharmaceuticals, Inc. worth $568K as of Q3 2019.
  • BB&T Securities bought 2,389 Portola Pharmaceuticals, Inc. shares in Q3 2019, an estimated $67.1K.
  • Portola Pharmaceuticals, Inc. made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #1050 holding.
  • BB&T Securities first reported a position in Portola Pharmaceuticals, Inc. in Q2 2018 and has held it in 5 quarters since.
  • 212 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.